The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that the company has recently finished the heavy phase of a major undertaking and has entered the collecting phase, with reported results still reflecting the paying phase. Transcript mentions several undertakings: MTA deployment (New York MTA). Matthew Siegel: "On the MTA deployment front, we are pleased to say we are very close to the completion of our initial build. Specifically, we expect to spend around $50 million on deployment in 2024 finishing our installation of advertisings being our non-staff. The annual capital investment will step down in 2025 as we look forward to replacement commences where our capital commitment." This indicates the heavy phase (deployment build) is nearly complete, but there is still about $50 million to spend in 2024, so not yet finished. They say "very close to the completion" but not done. Also, they expect capital investment to step down in 2025. So the heavy investment is ongoing in 2024, not yet finished. The collecting phase? The MTA deployment is about installing digital advertising in transit. They are finishing initial build. The revenue from that? They mention transit revenue recovery, but not specifically tied to MTA. Also, they say "we will continue to account for New York MTA franchise expense on a streamlined basis throughout the year." Not clear. Another undertaking: Sale of Canadian business. That's not a build. Digital conversions? They say they continue to opportunistically convert boards, expect 150-200 new boards. That's ongoing, not finished. Automated sales platform? That's growing, not a heavy phase. The question asks about a major undertaking with heavy phase completed, now collecting. The MTA deployment is the closest. But they say "very close to the completion" and expect to spend $50 million in 2024 to finish. So heavy phase is not done yet; they are still spending. Also, the payoff? They don't explicitly say the revenue from MTA is starting to arrive. They mention transit revenue recovery but not tied to completed MTA build. Also, the reported results still reflect the paying phase? They say AFFO growth high single digit driven by OIBDA improvement, but not specifically from MTA completion. No clear statement that the heavy phase is substantially done and the collecting phase has begun with lagging numbers. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.